Results 101 to 110 of about 12,399 (131)

Prevalence of contraindicated combinations amid behavioral and mental health medications filled in a pediatric population. [PDF]

BMC Prim Care
Borgelt LM, Bliss K, Matson J, Cajuste B, Kuang X, Toohey M, Pace W, Shemesh E, Lo S, Olczyk A, Gleason K, Pincus H, Kleinman LC.   +12 more
europepmc   +1 more source

Evaluation of Clinical Correlation between Insulin Resistance and Antipsychotic Drug Therapy in Patients with Schizophrenia. [PDF]

Actas Esp Psiquiatr
Wang F, Wang F, Tao X, Ni W, Li W, Lin J.   +5 more
europepmc   +1 more source

Clinical research updates. [PDF]

Child Adolesc Ment Health
Kyriakopoulos M, Vrigkou E, Kallinikos M, Maridaki Z.   +3 more
europepmc   +1 more source

Unusual Chronotropic Incompetence in a Young Patient: Mitigating the Fear of Fatal Bradyarrhythmia When Antipsychotics Are Deemed Necessary. [PDF]

Cureus
Patel PV, Desai YK, Khan M, Naseer ZA, Marney M, Exeer AM, Osmani GP, Sulliman M, Manalai P.   +8 more
europepmc   +1 more source

Chronotherapeutic considerations of benzodiazepine administration for agitation management in the emergency department. [PDF]

BMJ Ment Health
Rudisell E, Weant K, Porcu A.
europepmc   +1 more source

Real-World Effectiveness, Economic, and Humanistic Outcomes of Selected Oral Antipsychotics in Patients with Schizophrenia: A Systematic Review Evaluating Global Evidence. [PDF]

Clinicoecon Outcomes Res
Adhikari K, Kamal KM, Jeun KJ, Nolfi DA, Ashraf MN, Zacker C.   +5 more
europepmc   +1 more source